Blog

In a new episode of All Things Cancer, NFCR President and CEO Dr. Sujuan Ba interviews Dr. Monica Bertagnolli—former Director of both the National Cancer Institute and the National Institutes of Health. Their conversation touches on the state of U.S. cancer research, the challenges facing today’s scientific workforce, and how artificial intelligence may reshape patient care.

From Rural Roots to National Leadership

Growing up on a Wyoming cattle ranch, Dr. Bertagnolli learned firsthand how limited access to healthcare affects rural communities. That experience continues to guide her commitment to equity and to ensuring that innovations in cancer research reach every patient, regardless of geography.

Protecting the Future of Cancer Science

She expresses deep concern about unstable federal funding, noting its impact on labs, young scientists, and long-term discoveries. While there is bipartisan recognition of NIH’s importance, she stresses that philanthropy remains essential for sustaining cancer research during uncertain times.

AI in Medicine: Promise With Responsibility

AI could dramatically improve diagnosis and treatment, but Dr. Bertagnolli underscores that these tools must be backed by strong evidence and real-world data from diverse populations. Above all, patients and clinicians must trust how AI is used.

A Vision for Progress

She envisions a system where patient data is protected, reliable, and used to drive better outcomes—ensuring that the future of cancer care is more equitable, innovative, and effective.

About All Things Cancer

Each episode of All Things Cancer will spotlight the most pressing topics in oncology, from cutting-edge treatments and emerging research to personal stories of resilience and hope. More than just a podcast, it’s a platform for raising awareness, advancing cancer education, and fostering a global community of support and collaboration.

Hosted by NFCR CEO, Sujuan Ba, Ph.D., this compelling series will bring together the entire ecosystem of cancer research—including leading scientists, oncologists, doctors, patient advocates, caregivers, biotech innovators, and survivors—for powerful discussions on the breakthroughs shaping the future of cancer research, treatment, and care.

All Things Cancer is now available on Spotify and Apple Podcasts, with new episodes released biweekly.

Subscribe now to stay up to date on the latest episodes and join the conversation that’s shaping the future of cancer research. Cancer impacts everyone—whether you’re a patient, caregiver, advocate, or researcher, this podcast delivers invaluable insights from those on the frontlines of the fight against it.